CORONA acquires Myoril brand from Sanofi Healthcare
Express Pharma
JUNE 29, 2023
The acquisition of the Myoril brand for the Indian market is effective from June 28, 2023 CORONA Remedies has announced the acquisition of the Myoril brand from the global pharma giant Sanofi. The acquisition, valued at Rs 234 crore (including taxes), marks CORONA’s largest acquisition to date.
94 
Let's personalize your content